General Information of the Compound
Compound ID |
CP0060502
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
1-(6-(methylthio)naphthalen-2-yl)propan-2-amine
Show/Hide
|
||||||||||||||||||
Synonyms |
1-(6-(methylthio)naphthalen-2-yl)propan-2-amine
2-Amino-1-(4-methylthiophenyl)propane
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C10H15NS
|
||||||||||||||||||
Molecular Weight |
181.304
|
||||||||||||||||||
Canonical SMILES |
CSc1ccc(CC(C)N)cc1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C10H15NS/c1-8(11)7-9-3-5-10(12-2)6-4-9/h3-6,8H,7,11H2,1-2H3
Show/Hide
|
||||||||||||||||||
InChIKey |
OLEWMKVPSUCNLG-UHFFFAOYSA-N
|
||||||||||||||||||
CAS |
14116-06-4
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00884, Sodium-dependent dopamine transporter
Protein ID: PT01026, Sodium-dependent noradrenaline transporter
Protein ID: PT00871, Sodium-dependent serotonin transporter
Protein ID: PT00891, Sodium-dependent serotonin transporter
Cell Viability or Cytotoxicity Assay
Cell Line ID | Cell Line Name | Cell Line Organism | |
CL000004 | SH-SY5Y | Homo sapiens (Human) | 1 |
1 |
EC50 = 608135 nM
|
TI
LI
LO
TS
|
|
---|---|---|---|
CL000006 | HEK293 | Homo sapiens (Human) | 1 |
1 |
EC50 = 18620.87 nM
|
TI
LI
LO
TS
|
Clinical Information about the Compound